NIKI
Niki BioSolutions, Inc.Price
Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.
- X Jul 31 Short interest falls 63.0% to 24.8K
- X Aug 14 Short interest falls 82.6% to 4.3K
- X Aug 31 Short interest falls 36.4% to 2.7K
- E Sep 4 Trading halt: Halt Resumed: NIKI — trading resumed after LUDP (Volatilit…
- E Sep 4 Trading halt: Trading Halt: NIKI — LUDP (Volatility Trading Pause)
- X Sep 15 Short interest jumps 377.6% to 13.1K
- R Oct 2 Niki BioSolutions (NIKI) filed Pre-Effective Amendment No. 3 to its…
- X Oct 15 Short interest falls 60.6% to 5.8K
Signal stack
Where each data set points today.
- InsidersNO TRADES
No open-market buys or sells in 12 months. Recent filings are awards, exercises and tax withholding.
- InstitutionsMIXED
Q2 2026: 0 added (0 new), 1 trimmed or exited.
- Short sellersCOVERING
Short interest −60.6% to 5.8K shares. 1.0 days to cover, ≈0.2% of shares.
- TrendDOWNTREND
62% below its 50-day average. New closing low $1.83 on Oct 23.
- SocialQUIET
No Reddit mentions this week. Last mention Oct 13.
Who's buying
13F· Q2 2026| Fund | Move | Value |
|---|---|---|
| CITADEL ADVISORS LLC | TRIM | $19.2K |
Quarterly 13F filings are due 45 days after each quarter ends.
Insider ledger
Form 4| Date | Insider | Type | Value |
|---|---|---|---|
| Jul 22, 2026 | Sheinerman Kira Director | AWARD | 8,000 sh |
| Jul 22, 2026 | Philips Laura A Director | AWARD | 8,000 sh |
| Jul 22, 2026 | Sheinerman Kira Director | AWARD | 8,000 sh |
Earnings setup
Estimates| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | — | — | — | $0.00 |
| Next Q | — | — | — | $0.00 |
| Current FY | — | — | — | $0.00 |
| Next FY | — | — | — | $0.00 |
Short side
FINRA· Oct 15, 2026| Sep 4, 2026 | Volatility Pause | Resumed |
| Jul 21, 2026 | Volatility Pause | Resumed |
| Jul 21, 2026 | Volatility Pause | Resumed |
| Jul 21, 2026 | Volatility Pause | Resumed |
| Jul 20, 2026 | Volatility Pause | Resumed |
SecBot reports
5 filings · 1 press release · 0 bullish · 4 bearish · 1 neutral- BEARISH EFFECTOct 13, 2026
Niki BioSolutions' $75M universal shelf registration (File No. 333-298608) became effective on…
With the shelf now effective, watch for prospectus supplements indicating an actual takedown. The company's cash needs and going-concern status make a near-term offering likely. Any announcement of…
- BEARISH S-3/AOct 2, 2026
Niki BioSolutions (NIKI) filed Pre-Effective Amendment No. 3 to its S-3 shelf registration…
The shelf is a potential dilutive overhang, but the I.B.6 one-third rule severely limits any primary offering size. The company's financial distress and going-concern warning make any capital raise…
- NEUTRAL PRESS RELEASESep 25, 2026
Niki BioSolutions announced participation in the Lytham Partners Fall 2026 Investor Conference…
Monitor the webcast for any strategic or financial updates, but the primary near-term catalyst is the S-3 shelf registration — watch for any takedown announcements that would indicate dilutive…
- BEARISH S-3/ASep 18, 2026
Niki BioSolutions filed Pre-Effective Amendment No. 2 to its Form S-3 shelf registration…
Monitor for the first prospectus supplement or ATM takedown under this shelf, which would trigger actual dilution given the ~$1.68M annual cap. Watch for any update on the pending RICO/fraud lawsuit…
All NIKI filing & press-release reports (6)
- EFFECT reportOct 13, 2026
- S-3/A reportOct 2, 2026
- PRESS-RELEASE reportSep 25, 2026
- S-3/A reportSep 18, 2026
- S-3 reportAug 27, 2026
- 8-K reportAug 7, 2026